Effects of Leader Sleep Improvement on Leadership

The Effects of Leader Sleep Improvement on Leadership

The purpose of the study is to investigate the effects of sleep improvement in leaders on leader outcomes.

Study Overview

• Status: Unknown
• Conditions: Chronic Insomnia; Insomnia, Primary
• Intervention / Treatment: Other: Online Cognitive Behavioral Therapy for Insomnia (CBT-I)

Detailed Description

The investigators seek to extend the findings of a recent research which demonstrated that treating insomnia has several beneficial effects on employee work outcomes (Barnes, Miller, & Bostock, in press). In the present study, the investigators propose that the treatment of leader insomnia would beneficially influence leadership, specifically abusive supervision, charismatic leadership, and laissez-faire leadership.

• Study Type: Interventional
• Enrollment (Anticipated): 400
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Yu Tse Heng; Phone Number: 412-517-2941; Email: yutse@uw.edu

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion criteria:

• Working adults who have at least one direct report (i.e., subordinate).

Exclusion criteria:

• Non-working adults/ adults who do not have at least one direct report (i.e., subordinate).

Study Plan

How is the study designed?

Design Details

• Primary Purpose: OTHER
• Allocation: RANDOMIZED
• Interventional Model: PARALLEL
• Masking: NONE

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
EXPERIMENTAL: Experimental Condition; Online Cognitive Behavioral Therapy for Insomnia Intervention	Other: Online Cognitive Behavioral Therapy for Insomnia (CBT-I); CBT-I is a psychological treatment designed to break the patterns of maladaptive thinking and behavior that maintain insomnia. CBT-I includes a range of techniques including a behavioral component (stimulus control, sleep restriction, relaxation) combined with a cognitive component (managing sleep related worries, the racing mind and intrusive thoughts) and an educational (sleep hygiene) component.
NO_INTERVENTION: Control Condition; No intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Self-Control Scale	Rate self-control over the past 2 weeks. Each item is scored 1-5 (1 = Very slightly or not at all, 2 = A little, 3 = Moderately, 4 = Quite a bit, 5 = Extremely).	2 weeks
Abusive Supervision Scale	Rate abusive supervision over the past 2 weeks. Each item is scored 1-5: - I cannot remember him/her ever using this behavior with me; - He/she very seldom uses this behavior with me; - He/she occasionally uses this behavior with me; - He/she uses this behavior moderately often with me; - He/she uses this behavior very often with me	2 weeks
Emotional Labor Scale	Rate emotional labor over the past 2 weeks. Each item is scored 1-5 (1 = Very slightly or not at all, 2 = A little, 3 = Moderately, 4 = Quite a bit, 5 = Extremely).	2 weeks
Charismatic Leadership Scale	Rate charismatic leadership over the past 2 weeks. Each item is scored 1-5 (1 = to a very little extent; 2 = to a little extent; 3 = to a moderate extent; 4 = to a great extent; 5 = to a very great extent).	2 weeks
Emotional Exhaustion Scale	Rate emotional exhaustion over the past 2 weeks. Each item is scored 1-5 (1 = Very slightly or not at all, 2 = A little, 3 = Moderately, 4 = Quite a bit, 5 = Extremely).	2 weeks
Laissez-Faire Leadership Scale	Rate laissez-faire leadership over the past 2 weeks. Each item is scored 1-5 (1 = to a very little extent; 2 = to a little extent; 3 = to a moderate extent; 4 = to a great extent; 5 = to a very great extent).	2 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Insomnia Scale	Rate insomnia over the past 2 weeks. Each item is scored 1-5 (1 = Very slightly or not at all, 2 = A little, 3 = Moderately, 4 = Quite a bit, 5 = Very much)	2 weeks

Collaborators and Investigators

• Sponsor: University of Washington
• Investigators: Principal Investigator: Yu Tse Heng, University of Washington

Study record dates

Study Major Dates

• Study Start (ANTICIPATED): January 1, 2018
• Primary Completion (ANTICIPATED): June 1, 2018
• Study Completion (ANTICIPATED): June 1, 2018

Study Registration Dates

• First Submitted: January 5, 2017
• First Submitted That Met QC Criteria: January 6, 2017
• First Posted (ESTIMATE): January 9, 2017

Study Record Updates

• Last Update Posted (ACTUAL): October 26, 2017
• Last Update Submitted That Met QC Criteria: October 24, 2017
• Last Verified: October 1, 2017

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Mental Disorders; Nervous System Diseases; Sleep Disorders, Intrinsic; Dyssomnias; Sleep Wake Disorders; Sleep Initiation and Maintenance Disorders
• Other Study ID Numbers: STUDY00000461-B

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No